Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Clinical trial NCT03480971 · RECRUITING

Trial details

NCT number: NCT03480971
Sponsor: Matrix Biomed, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mucositis Nephrotoxicity Ototoxicity

Start date: 2019-05-13
Primary completion: 2025-07-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.